The Urea Cycle Disorder Market was valued at USD 0.5 billion in 2024 and is projected to reach USD 1.2 billion by 2034, registering a CAGR of 8.5%. This growth trajectory is underpinned by several key factors, including the rising prevalence of urea cycle disorders, advancements in treatment options, and increasing awareness among healthcare professionals and patients. The growing demand for...